Cargando…
Clinical and molecular sub-classification of hepatocellular carcinoma relative to alpha-fetoprotein level in an Asia-Pacific island cohort
AIM: Increased serum alpha-fetoprotein (AFP) levels are associated with specific molecular sub-classes of hepatocellular carcinoma (HCC), supporting AFP as a predictive or therapeutic biomarker for precision treatment of this disease. Considering recent efforts to validate HCC molecular classificati...
Autores principales: | Nishioka, Scott T., Sato, Miles M., Wong, Linda L., Tiirikainen, Maarit, Kwee, Sandi A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786161/ https://www.ncbi.nlm.nih.gov/pubmed/29376136 http://dx.doi.org/10.20517/2394-5079.2017.46 |
Ejemplares similares
-
Hepatocellular carcinoma in Pacific Islanders: comparison of Pacific Island-born vs. US-born
por: Yee, Shelby K., et al.
Publicado: (2023) -
Beta-catenin activation and immunotherapy resistance in hepatocellular carcinoma: mechanisms and biomarkers
por: Kwee, Sandi A., et al.
Publicado: (2021) -
Elucidating the Landscape of Aberrant DNA Methylation in Hepatocellular Carcinoma
por: Song, Min-Ae, et al.
Publicado: (2013) -
Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity
por: Wang, Xiaoping, et al.
Publicado: (2018) -
Clinical Significance of Alpha-Fetoprotein in Alpha-Fetoprotein Negative Hepatocellular Carcinoma Underwent Curative Resection
por: Lin, Kongying, et al.
Publicado: (2021)